Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BIO-key International, Inc. - Common Stock (NQ:BKYI)

0.7890 -0.0300 (-3.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about BIO-key International, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
11 Information Technology Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Information Technology Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Crude Oil Dips Over 4%; OPEC Cuts Global Oil Demand Outlook
Via Benzinga
Exposures Fossil Fuels
BKYI Stock Earnings: BIO-key Intl Reported Results for Q2 2024
BIO-key Intl just reported results for the second quarter of 2024. 
Via InvestorPlace
BKYI Stock Earnings: BIO-key Intl Reported Results for Q1 2024
BIO-key Intl just reported results for the first quarter of 2024. 
Via InvestorPlace
BKYI Stock Earnings: BIO-key Intl Misses Revenue for Q4 2023
BKYI stock results show that BIO-key Intl missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Dow Dips Around 1%; US Small Business Optimism Falls In August
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Mixed; Oracle Posts Upbeat Results
Via Benzinga
BIO-key Reveals Strategic Move To AWS Marketplace Amid Q2 Revenue Challenges: Details
BIO-key expands global reach and customer base by listing its PortalGuard IDaaS platform on AWS Marketplace. Q2 2024 results show improved net loss and cash usage. 
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Earnings Scheduled For April 1, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million. 
Via Benzinga
11 Information Technology Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update. 
Via Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Biometric Solutions Provider BIO-key Shares Are Trading Higher Today
BIO-key International Inc (NASDAQ: BKYI) disclosed Carrefour (OTC: CRRFY) is integrating the AuthControl Sentry cloud solution in Spain in partnership with Evolutio, BIO-key's  
Via Benzinga
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.